For Breast Self-Examination, Once A Month Is Quite Enough

March 22, 1999

Too much breast self-examination can be counterproductive for women with a family history of breast cancer, according to a team of British scientists. Not that monthly breast self-examination isn't an effective way of detecting early symptoms of breast cancer for women with a family history of the disease. More than 90 percent of breast cancers are found by women themselves, some studies show.

But examining one's breasts every week or every day does not improve detection of symptoms; it may in fact reduce the efficacy of the procedure, according to a report in the March issue of Psychosomatic Medicine.

"Women who over-examine may be substituting frequent yet cursory self-examinations for thorough and effective ones," says Kate Brain, Ph.D., of the University of Wales College of Medicine, who led the research team.

"Excessively frequent self-examination can also make early detection of breast cancer symptoms more difficult by increasing the likelihood of false-positive findings," Brain says.

The researchers, who also included Sheffield University psychologists, surveyed 833 women who have family histories of breast cancer. About 18 percent said they examine themselves for breast cancer daily or weekly. Fifty-six percent reported that they follow the recommended frequency of once or twice a month. At the low end of the spectrum were 26 percent of the at-risk women who rarely or never examine themselves.

Some earlier studies suggested that those who rarely examined their breasts were hindered by fears and anxieties. However, the Wales/Sheffield scientists found that cancer-specific anxiety was lowest among the women who examined themselves least often and highest among those who examined themselves most often. High general anxiety was found only among the hyper-vigilant women who examined themselves daily or weekly.

Current health promotion efforts seek mostly to alert and motivate at-risk women at the low end of the self-examination scale. For the high-end self-examiners, these programs need to be broadened to include the message that daily or weekly examinations may not improve cancer detection, the researchers said.

"A delicate balance needs to be achieved between managing anxiety and maintaining optimal adherence to breast self-examination," they conclude.
-end-
Psychosomatic Medicine is the official peer-reviewed journal of the American Psychosomatic Society, published bimonthly. For information about the journal, contact Joel E. Dimsdale, MD, editor-in-chief, at 619-543-5468.

Posted by the Center for the Advancement of Health http://www.cfah.org. For information about the Center, contact Petrina Chong pchong@cfah.org, 202-387-2829.



Center for Advancing Health

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.